Oncology & Cancer
Imaging after thyroid cancer treatment does not necessarily mean better outcomes
More imaging after thyroid cancer treatment identifies recurrence, but it does not always improve survival, a new study suggests.
Jul 20, 2016
0
0
News tagged with radioactive iodine
Oncology & Cancer
Radioactive iodine treatment in women affects ovarian reserve and may affect fertility
Women of reproductive age who have thyroid cancer should be cautious about receiving radioactive iodine treatment, which affects their remaining egg supply - their ovarian reserve - and may affect their fertility, new research ...
Apr 3, 2016
0
1
Oncology & Cancer
Advanced thyroid cancer responds to targeted therapy with sunitinib
In patients with advanced thyroid cancer, sunitinib, a drug approved for treatment of several other cancers, showed significant cancer-fighting activity t, a new phase 2 clinical trial has found. Results of the single-center ...
Mar 8, 2015
0
9
Oncology & Cancer
Radiation exposure linked to aggressive thyroid cancers
For the first time, researchers have found that exposure to radioactive iodine is associated with more aggressive forms of thyroid cancer, according to a careful study of nearly 12,000 people in Belarus who were exposed when ...
Oct 28, 2014
0
1
Oncology & Cancer
Sorafenib shows success in advanced differentiated thyroid cancer patients
(Medical Xpress)—The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to a new study from researchers in the Abramson Cancer Center at the University ...
Apr 25, 2014
0
0
Oncology & Cancer
Engineered virus is effective against triple negative breast cancer cells
Scientists have discovered a potential cure for one of the most aggressive and least treatable forms of breast cancer called "triple negative breast cancer." In laboratory experiments involving human cancer cells, scientists ...
Jan 30, 2014
0
0
Oncology & Cancer
Genetic factors behind radiation-induced thyroid cancer
Scientists have long sought to determine whether heredity is one of the factors responsible for increased risk of thyroid cancer, but their results have been inconclusive... until now.
Dec 4, 2013
0
0
Oncology & Cancer
Nexavar approval expanded for common thyroid cancer
(HealthDay)—U.S. Food and Drug Administration approval for the anti-cancer drug Nexavar (sorafenib) has been expanded to include late-stage differentiated thyroid cancer, the most common type of thyroid cancer.
Nov 24, 2013
0
0
Oncology & Cancer
Targeted therapy sorafenib shows success in advanced differentiated thyroid cancer patients
The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to results of a randomized phase III trial, which will be presented today by a researcher ...
Jun 2, 2013
0
0
Oncology & Cancer
Terbium: A new 'Swiss Army knife' for cancer diagnosis and treatment
A collaboration between the Paul Scherrer Institute, CERN's ISOLDE facility, and the Institut Laue-Langevin, has published preclinical study results for a newly developed set of tumour-targeting radiopharmaceuticals. The ...
Dec 24, 2012
0
1
